Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...

Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...

A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.